GlassScriptPhysician profile
Priya Vaidya
NPI 1730419532
$1,950.58
in general payments reported to CMS, 2019-2025
26 companies · $941 in 2025
The $941 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $514 · 2024: $495 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,950.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $324.79 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.53 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $182.27 | 2023-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $177.63 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $128.00 | 2023-2025 | Verquvo, Zerbaxa |
| Novartis Pharmaceuticals Corporation | $121.05 | 2023-2025 | |
| Abbott Laboratories | $120.71 | 2023-2025 | Freestyle Libre 3 |
| Amgen INC. | $102.37 | 2023-2025 | Otezla, Repatha, Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $85.53 | 2024-2025 | |
| Corcept Therapeutics | $76.33 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $71.10 | 2025 | Cologuard Collection Kit |
| Actelion Pharmaceuticals US, INC. | $33.35 | 2024 | Opsumit |
| Inspire Medical Systems, INC. | $33.05 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $30.99 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $30.20 | 2023 | Xarelto |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $24.88 | 2025 | |
| Sanofi Pasteur INC. | $22.82 | 2023 | |
| Boston Scientific Corporation | $20.29 | 2023 | Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $18.99 | 2025 | Camzyos |
| Abbvie INC. | $18.00 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $17.40 | 2023 | Rexulti |
| Globus Medical, INC. | $17.25 | 2025 | Senza |
| Tactile Systems Technology INC | $15.83 | 2023 | Entre Plus, Flexitouch Plus |
| Phathom Pharmaceuticals, INC. | $14.92 | 2024 | Voquezna |
| Philips North America LLC | $13.70 | 2024 | (Ck4) Mcot |
| Bridgebio Pharma, INC. | $13.60 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Vaidya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.